FDA ANDA · ANDA202503

SILDENAFIL CITRATE

Sponsor: WATSON LABS INC

APPLICATION

ANDA202503

TYPE

ANDA

ORIGINAL APPROVAL

2012-11-06

LATEST ACTION

2015-12-21

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

Prescription

Products

SILDENAFIL CITRATEPrescription

SILDENAFIL CITRATE EQ 20MG BASE · TABLET · ORAL

2015-12-21Labeling · Supplement 3 · standardAP

2015-12-21Labeling · Supplement 1 · standardAP

2015-03-16Labeling · Supplement 2 · standardAP

2012-11-06UNKNOWN · Original — Letter ↗AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.